The rapid development of information technologies, simulation software packages, and medical devices in recent years provides the opportunity for collecting a large amount of clinical information. Creating comprehensive and detailed computational tools has, therefore, become essential to process specific information from the abundance of available data.
From the physicians' point of view, it is of paramount importance to distinguish "normal" versus "abnormal" phenotypes in a specific patient to estimate disease progression, therapeutic responses, and future risks. Recent computational models have significantly improved the integrative understanding of the behavior of heart muscles in hypertrophic (HCM) and dilated (DCM) cardiomyopathies1. It is crucial to use a high-resolution, detailed, and anatomically accurate model of whole-heart electrical activity, which necessitates massive computation times, dedicated software, and supercomputers1,2,3. A methodology for a real 3D heart model has been recently developed using a linear elastic and orthotropic material model based on Holzapfel experiments, which can accurately predict the electrical signal transport and displacement field within heart4. The development of novel integrative modeling approaches could be an effective tool for distinguishing the type and severity of symptoms in patients with multigenic disorders and assessing the degree of impairment in normal physical activity.
There are, however, many new challenges for patient-specific modeling. The physical and biological properties of the human heart are not possible to fully determine. Non-invasive measurements usually include noisy data from which it is difficult to estimate specific parameters for the individual patient. Large-scale computation requires a lot of time to run, whereas the clinical time frame is limited. Patient personal data should be managed in such a way that generated metadata can be reused without compromising patient confidentiality. Despite these challenges, multi-scale heart models can include a sufficient level of detail to achieve predictions that closely follow observed transient responses, thereby providing promise for prospective clinical applications.
However, regardless of the substantial scientific effort by multiple research labs and the significant amount of grant support, currently, there is only one commercially available software package for multiscale and whole heart simulations, called SIMULIA Living Heart Model5. It includes dynamic electro-mechanical simulation, refined heart geometry, a blood flow model, and complete cardiac tissue characterization, including passive and active characteristics, fibrous nature, and electrical pathways. This model is targeted for use in personalized medicine, but the active material characterization is based on a phenomenological model introduced by Guccione et al.6,7. Therefore, SIMULIA cannot directly and accurately translate the changes in contractile protein functional characteristics observed in numerous cardiac diseases. These changes are caused by mutations and other abnormalities at the molecular and subcellular levels6. The limited use of SIMULIA software for a small number of applications in clinical practice is a great example of today's struggles in developing higher-level multiscale human heart models. On the other hand, it motivates the development of a new generation of multiscale program packages that can trace the effects of mutations from the molecular to organ scale.
The main aim of electrophysiology of the heart is to determine signal propagation inside the torso and the properties of all compartments4,5,6. The SILICOFCM8 project predicts cardiomyopathy disease development using patient-specific biological, genetic, and clinical imaging data. It is achieved with multiscale modeling of the realistic sarcomeric system, the patient's genetic profile, muscle fiber direction, fluid-structure interaction, and electrophysiology coupling. The effects of left ventricle deformation, mitral valve motion, and complex hemodynamics give detailed functional behavior of the heart conditions in a specific patient.
This article demonstrates the use of the SILICOFCM platform for a parametric model of the left ventricle (LV) generated automatically from patient-specific ultrasound images using a fluid-structure heart model with electromechanical coupling. Apical view and M-mode view analyses of LV were generated with a deep learning algorithm. Then, using the mesh generator, the finite element model was built automatically to simulate different boundary conditions of the full cycle for LV contraction9. On this platform, users can directly visualize the simulation results such as pressure-volume, pressure-strain, and myocardial work-time diagrams, as well as animations of different fields such as displacements, pressures, velocity, and shear stresses. Input parameters from specific patients are geometry from ultrasound images, velocity profile in the input and output boundary flow conditions for LV, and specific drug therapy (e.g., entresto, digoxin, mavacamten, etc.).